Arecor Therapeutics plc (AIM:AREC)

London flag London · Delayed Price · Currency is GBP · Price in GBX
77.50
-6.50 (-7.74%)
Oct 7, 2025, 3:16 PM GMT+1
-7.74%
Market Cap31.72M
Revenue (ttm)5.06M
Net Income (ttm)-8.10M
Shares Out37.76M
EPS (ttm)-0.22
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume63,946
Average Volume37,449
Open78.00
Previous Close84.00
Day's Range76.00 - 83.00
52-Week Range35.40 - 100.00
Beta-0.28
RSI81.11
Earnings DateSep 11, 2025

About Arecor Therapeutics

Arecor Therapeutics plc, a clinical stage biotechnology company, develops innovative medicines that address significant unmet patient needs in the United Kingdom. The company through its proprietary reformulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products. It also offers Ogluo which is used to treat severe hypoglycaemia events in patients with diabetes;... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 44
Stock Exchange London Stock Exchange AIM
Ticker Symbol AREC
Full Company Profile

Financial Performance

In 2024, Arecor Therapeutics's revenue was 5.05 million, an increase of 10.50% compared to the previous year's 4.57 million. Losses were -10.24 million, 19.7% more than in 2023.

Financial Statements

News

Half Year 2025 Arecor Therapeutics PLC Earnings Presentation Transcript

Half Year 2025 Arecor Therapeutics PLC Earnings Presentation Transcript

12 days ago - GuruFocus

AIM Market Roundup: Wishbone, Nativo Resources, Arecor Therapeutics

Wishbone, Nativo Resources, Arecor Therapeutics, Proteome Sciences and Bradda Head Lithium are today's top movers on London's AIM market

12 days ago - The Armchair Trader

LGND: Ligand Pharmaceuticals Inks $11M Royalty Deal with Arecor

LGND: Ligand Pharmaceuticals Inks $11M Royalty Deal with Arecor

12 days ago - GuruFocus

Arecor extends cash runway with US partnerships

Arecor has bolstered its balance sheet and sharpened its clinical focus, signing two US partnerships that will accelerate its drug pipeline.

12 days ago - The Armchair Trader

AIM Market Roundup: The Revel Collective, Tanfield, Arecor

The Revel Collective, Tanfield, Arecor are today's top risers, while Pantheon Resources, Acuity RM take the biggest fall on London's AIM

5 months ago - The Armchair Trader

Full Year 2024 Arecor Therapeutics PLC Earnings Presentation (Shareholder Q&A) Transcript

Full Year 2024 Arecor Therapeutics PLC Earnings Presentation (Shareholder Q&A) Transcript

5 months ago - GuruFocus

Half Year 2024 Arecor Therapeutics PLC Earnings Presentation Transcript

Half Year 2024 Arecor Therapeutics PLC Earnings Presentation Transcript

1 year ago - GuruFocus